Patent Application
App. No. 18/213,019
1,2,5-Oxadiazoles As Inhibitors Of Indoleamine 2,3- Dioxygenase
Loading inventors, assignments & file history…
Abstract
The present invention is directed to 1,2,5-oxadiazole derivatives, and compositions of the same, which are inhibitors of indoleamine 2,3-dioxygenase and are useful in the treatment of cancer and other disorders, and to the processes and intermediates for making such 1,2,5-oxadiazole derivatives.
Claims (7)
1 . A compound of Formula I:
or a pharmaceutically acceptable salt thereof, wherein:
R 1 is NH 2 or CH 3 ;
R 2 is Cl, Br, CF 3 , CH 3 , or CN;
R 3 is H or F; and
n is 1 or 2.
2 .- 174 . (canceled)
Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Dec 6, 2023
From: COMBS, ANDREW P.; YUE, EDDY W.; SPARKS, RICHARD B.; ZHU, WENYU; ZHOU, JIACHENG; LIN, QIYAN; WENG, LINGKAI; YUE, TAI-YUEN; LIU, PINGLI
To: INCYTE CORPORATION
Reel/Frame 065774/0784 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Dec 6, 2023
From: INCYTE CORPORATION
To: INCYTE CORPORATION; INCYTE HOLDINGS CORPORATION
Reel/Frame 065774/0871 →